Defiance Quantum ETF (AMEX:QTUM)
Historical Stock Chart
From Nov 2019 to Nov 2024
The Quantum Group Executes Plan to Expand Medicare Advantage
Options to Include Seven Florida Counties
WELLINGTON, Fla., Feb. 10 /PRNewswire-FirstCall/ -- The Quantum Group, Inc.
(OTC:QTUM) (BULLETIN BOARD: QTUM) announced today that it has executed a
second Letter of Intent with a Florida Health Maintenance Organization (HMO) to
build and manage a new Medicare Advantage Community Health System (CHS) in an
additional five Florida counties, bringing Quantum's CHS to seven counties.
"Through this newly expanded territory and other opportunities currently in
negotiation and development, we expect to have material operations before the
end of 2005 and have aggressive CHS expansion into 2006," commented Noel J.
Guillama, president of The Quantum Group, Inc.
Mr. Guillama further commented, "We now have a mandate to build and manage
Community Health Systems in seven of the most dynamic and growing counties in
Florida. These counties collectively have a total Medicare-eligible population
of over 400,000 individuals -- of which approximately only 75,000 are currently
enrolled in the Medicare Advantage program. We seek to provide more
alternatives to the more than 375,000 people that have not joined the program."
Renaissance Health Systems (RHS), a division of the Quantum family of
companies, will be responsible for the management of the day-to-day operations.
The mission of RHS is to provide quality, proactive, and cost effective
healthcare to our patients, while simultaneously improving their quality of
life and lifestyle.
The Quantum Group, Inc. is a Wellington, Florida-based healthcare company,
providing outsourcing, technology-based solutions, government compliance,
education, policy consulting and venture management to the healthcare industry.
Quantum is currently involved in: outsourcing for physicians, managed care
organizations, healthcare facilities, and physician associations; developing
three patent-pending healthcare solutions identified as Cybernaptics(SM),
Quantum Quotient(SM) (or QX2)(SM) and MDAutomated(SM), all with the intention
to provide new efficiencies to the $1.79 trillion U.S. healthcare system; and
providing leading-edge healthcare services to consumers. The Quantum Group --
"healthcare solutions for a new generation."(SM)
Certain statements contained in this news release, which are not based on
historical facts, are forward-looking statements as the term is defined in the
Private Securities Litigation Reform Act of 1995, and are subject to
uncertainties and risks in part detailed in the respective company's Securities
and Exchange Commission 10-K, 10-Q, S-8 and 8-K filings, that may cause actual
results to materially differ from projections. Although the company believes
that its expectations are reasonable assumptions within the bounds of its
knowledge of its businesses and operations; there can be no assurance that
actual results will not differ materially from their expectations. Important
factors currently known to management that could cause actual results to differ
materially from those in forward-looking statements include the company's
ability to execute properly its new business model, to raise additional capital
to implement new business model, the ability to attract and retain personnel,
and the inherent risk associated with a diversified business to achieve
positive cash flow. In light of these risks and uncertainties, there can be no
assurance that the forward-looking information contained in this report will,
in fact, occur.
Media Contact:
Danielle Amodio
Director of Corporate Communications
The Quantum Group, Inc.
561.798.9800
DATASOURCE: The Quantum Group, Inc.
CONTACT: Danielle Amodio, Director of Corporate Communications, The
Quantum Group, Inc., +1-561-798-9800
Web site: http://www.thequantumgroupinc.com/